Do I really need a blood thinner just because I have AF?

Not automatically — it depends on your stroke risk. Atrial fibrillation lets blood pool and clot in the heart, and those clots can travel to the brain, which is why AF raises stroke risk several-fold. But that risk varies a lot from person to person. Australian practice estimates it with the CHA₂DS₂-VA score, which adds up factors like age, blood pressure, diabetes and past stroke. A low score may mean no blood thinner is needed; a higher score means the benefit usually outweighs the bleeding risk. It's a calculation to do with your GP, not a blanket rule.

Warfarin or one of the newer tablets (DOACs) — which is better?

For most people with non-valvular AF, the newer direct oral anticoagulants (DOACs) — such as apixaban, rivaroxaban and dabigatran — are now preferred over warfarin in Australia. They work at a fixed dose, don't need regular blood-level monitoring, and have fewer food and medicine interactions. Warfarin is still the right choice in particular situations, most importantly a mechanical heart valve or significant rheumatic mitral valve disease, where DOACs are not suitable. Which one fits you depends on your kidneys, other medicines and your circumstances — a conversation for your GP.

What is the CHA₂DS₂-VA score, and why does mine look different from someone else's?

It's a simple points system that estimates your yearly stroke risk from AF, using age, high blood pressure, diabetes, heart failure, vascular disease and any previous stroke. The higher the score, the more a blood thinner tends to help. Australia uses a version called CHA₂DS₂-VA, which — unlike the older CHA₂DS₂-VASc — does not add a point just for being female, so your score here may be one lower than a calculator you find online. You can work through it on the calculator linked below and take the number to your GP.

My bleeding-risk (HAS-BLED) score is high — does that mean I shouldn't take a blood thinner?

Usually not. A high HAS-BLED score is best understood as a prompt to fix the bleeding risks you can change — blood pressure control, reviewing other medicines like anti-inflammatories, cutting back alcohol — rather than as a reason to withhold protection from stroke. Australian guidance is clear that a higher bleeding score should alert you and your doctor, but should not by itself discourage anticoagulation. The honest move is to see the stroke benefit and the bleeding risk side by side and decide together.

Can't I just take aspirin instead — isn't that gentler?

For stroke prevention in AF, aspirin is no longer recommended as a substitute for proper anticoagulation. It's much less effective at preventing AF-related strokes and still carries bleeding risk, so it doesn't offer the gentle middle ground people often hope for. If you're currently taking aspirin or any blood thinner, don't change it on your own — that's a conversation to have with your GP, who can look at your full picture.

Decision aid

Atrial fibrillation — blood thinners, stroke risk and bleeding risk

By Dr HB Lo, FACRRM Reviewed 15 June 2026 4 min read

General information to help you prepare for your GP — not a diagnosis, not personal medical advice. It doesn't replace a consultation, and using it doesn't create a doctor–patient relationship.

If you have atrial fibrillation (AF) and a blood thinner has come up, you're really weighing two things at once: how much it lowers your risk of a stroke, against how much it raises your risk of bleeding. The decision is about getting both onto the same table at their true sizes.

In Australia the stroke side is estimated with a score (CHA₂DS₂-VA), the bleeding side with another (HAS-BLED). For most people with non-valvular AF the newer tablets — the DOACs — are now preferred over warfarin, though warfarin is still right in specific situations such as a mechanical heart valve.

This guide walks through how that decision is made, so you can take clear questions to your GP.

Two risks on one table — that’s the whole decision

Being told you have atrial fibrillation, and then hearing the words “blood thinner,” can feel like a door closing. It isn’t. What’s actually being weighed is a trade-off you’re allowed to understand in full: how much a blood thinner cuts your chance of a stroke, set against how much it raises your chance of a serious bleed. Get both onto the same table, at their real sizes, and the decision stops feeling like a gamble and starts looking like a calculation — which is exactly what it is.

This guide walks through how that calculation is done in Australian general practice, so the questions you take to your GP are the ones that matter.

Why AF raises stroke risk in the first place

In atrial fibrillation the top chambers of the heart quiver instead of beating cleanly, so blood can pool and form a clot. If that clot travels to the brain, it causes a stroke. That’s why AF raises stroke risk several-fold compared with a regular heart rhythm, as the Heart Foundation and HealthDirect explain. A blood thinner (anticoagulant) reduces the chance of those clots forming — and across the people who take one, it prevents a large share of AF-related strokes, per Australian Prescriber.

But the size of your stroke risk varies enormously depending on your age and other conditions. That’s the first thing to pin down.

Step one: your stroke risk (the CHA₂DS₂-VA score)

Australian practice estimates AF stroke risk with a points system called CHA₂DS₂-VA, drawing on age, high blood pressure, diabetes, heart failure, vascular disease and any previous stroke, as set out in the RACGP’s AF review and the NHFA/CSANZ guideline. One Australian wrinkle worth knowing: our guidelines use the “sexless” CHA₂DS₂-VA version, which — unlike the older CHA₂DS₂-VASc you’ll find on many overseas calculators — does not add a point simply for being female, per Australian Prescriber. So your Australian score may come out one lower.

A low score may mean a blood thinner isn’t needed; a higher score means the protection usually outweighs the bleeding risk. You can work through your own score on the CHA₂DS₂-VA / CHA₂DS₂-VASc calculator and bring the number to your GP.

Step two: your bleeding risk (the HAS-BLED score)

The other side of the table is bleeding. Australian practice estimates it with the HAS-BLED score, which looks at things like blood pressure control, kidney or liver problems, past bleeding, alcohol and certain medicines, per Australian Prescriber. Here’s the part people most often get wrong: a high HAS-BLED score is not a reason to skip anticoagulation. Australian guidance is explicit that a higher bleeding score should alert you and your doctor, but should not by itself discourage protection from stroke.

Instead, a high score is a to-do list. Several of its points come from things you can actually change — getting blood pressure under control, reviewing anti-inflammatory medicines, cutting back alcohol. You can see which of your points are modifiable on the HAS-BLED score calculator and turn it into a fix-list for your GP.

Warfarin or a DOAC?

Once anticoagulation is on the table, the next fork is which one. For most people with non-valvular AF, the newer direct oral anticoagulants (DOACs) — apixaban, rivaroxaban and dabigatran — are now preferred over warfarin in Australia, per Australian Prescriber and the RACGP. They work at a fixed dose, don’t need the regular blood-level checks that warfarin does, and have fewer food and medicine interactions.

Warfarin still has clear, specific roles. It remains the right choice — and DOACs are not suitable — for people with a mechanical heart valve or significant rheumatic mitral valve disease, per Australian Prescriber. Warfarin’s effect is tracked with a blood test called the INR, which is why it needs ongoing monitoring, as HealthDirect describes. Which option fits you also depends on your kidney function and your other medicines, drawing on the Australian Medicines Handbook and Therapeutic Guidelines.

The blood-thinner-for-AF decision aid below lays the warfarin-versus-DOAC trade-off out in plain terms so you can prepare that conversation rather than be swept along. None of this tells you which medicine to take — that’s a decision for you and your GP.

And aspirin?

For years, some people were offered aspirin as a “gentler” alternative for AF. The evidence moved: aspirin is no longer recommended as a substitute for proper anticoagulation in AF, because it’s much less effective at preventing AF-related strokes while still carrying bleeding risk, per Australian Prescriber and HealthDirect. If you’re currently on aspirin or any blood thinner, the message is “ask,” not “change it yourself.”

The questions worth taking in

What’s my CHA₂DS₂-VA stroke score, and what would a blood thinner actually change about it?
What’s my HAS-BLED score, and which of those bleeding risks can I work on?
For me specifically, would a DOAC or warfarin suit better — and why?
If I start, how will we check it’s working and not causing problems?

These are questions, not conclusions. The aim is to decide with your GP, with both risks in plain view.

What this is, and is not

This is general information to help you prepare for your GP — not a diagnosis, and not personal medical advice. It doesn’t tell you to start, stop or change any medicine; those decisions are made with your own doctor, who can weigh your actual scores and history. For trustworthy Australian background, see HealthDirect and the Heart Foundation.

Related on this site: the atrial fibrillation explainer covers the rhythm itself in more depth, and if a procedure is also on the table the heart procedures decision aid and the cardiovascular prevention decision aid sit alongside this one.

If you want a thorough, unhurried review of your own AF and stroke-prevention picture, you can work with Dr Lo.

Author: Dr Hoe Bing Lo — AHPRA MED0001212640 · FACRRM. Fun Doctors Pty Ltd · ABN 83 404 436 330.

Tools to take to your GP

Each runs in your browser — nothing you enter is stored or sent anywhere. They help you prepare the questions and print a one-page summary to bring to your appointment. They don't diagnose or recommend a specific treatment.

Decision tool Blood thinner for AF Open tool →

Frequently asked questions

Do I really need a blood thinner just because I have AF?

Not automatically — it depends on your stroke risk. Atrial fibrillation lets blood pool and clot in the heart, and those clots can travel to the brain, which is why AF raises stroke risk several-fold. But that risk varies a lot from person to person. Australian practice estimates it with the CHA₂DS₂-VA score, which adds up factors like age, blood pressure, diabetes and past stroke. A low score may mean no blood thinner is needed; a higher score means the benefit usually outweighs the bleeding risk. It's a calculation to do with your GP, not a blanket rule.
Warfarin or one of the newer tablets (DOACs) — which is better?

For most people with non-valvular AF, the newer direct oral anticoagulants (DOACs) — such as apixaban, rivaroxaban and dabigatran — are now preferred over warfarin in Australia. They work at a fixed dose, don't need regular blood-level monitoring, and have fewer food and medicine interactions. Warfarin is still the right choice in particular situations, most importantly a mechanical heart valve or significant rheumatic mitral valve disease, where DOACs are not suitable. Which one fits you depends on your kidneys, other medicines and your circumstances — a conversation for your GP.
What is the CHA₂DS₂-VA score, and why does mine look different from someone else's?

It's a simple points system that estimates your yearly stroke risk from AF, using age, high blood pressure, diabetes, heart failure, vascular disease and any previous stroke. The higher the score, the more a blood thinner tends to help. Australia uses a version called CHA₂DS₂-VA, which — unlike the older CHA₂DS₂-VASc — does not add a point just for being female, so your score here may be one lower than a calculator you find online. You can work through it on the calculator linked below and take the number to your GP.
My bleeding-risk (HAS-BLED) score is high — does that mean I shouldn't take a blood thinner?

Usually not. A high HAS-BLED score is best understood as a prompt to fix the bleeding risks you can change — blood pressure control, reviewing other medicines like anti-inflammatories, cutting back alcohol — rather than as a reason to withhold protection from stroke. Australian guidance is clear that a higher bleeding score should alert you and your doctor, but should not by itself discourage anticoagulation. The honest move is to see the stroke benefit and the bleeding risk side by side and decide together.
Can't I just take aspirin instead — isn't that gentler?

For stroke prevention in AF, aspirin is no longer recommended as a substitute for proper anticoagulation. It's much less effective at preventing AF-related strokes and still carries bleeding risk, so it doesn't offer the gentle middle ground people often hope for. If you're currently taking aspirin or any blood thinner, don't change it on your own — that's a conversation to have with your GP, who can look at your full picture.

Source quality

Sources grouped by evidence tier. Australian primary tier first; international where Australia is silent or lagging. How tiers work.

T1 AU primary 10 sources

If you want a thorough, unhurried work-up of your own — not a generic answer — you can work with Dr Lo.